A PHASE-II STUDY OF ANTITUMOR EFFICACY AND SAFETY OF EXEMESTANE (EXE)AS 3RD-LINE HORMONAL TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER (MBC) REFRACTORY TO TAMOXIFEN AND MEGACE(TM)

Authors
JONES S VOGEL C FEHRENBACHER L EISENBERG P ARKHIPOV A TIFFANY J POLLI A WHALEY F DISALLE E MILLER L
Citation
S. Jones et al., A PHASE-II STUDY OF ANTITUMOR EFFICACY AND SAFETY OF EXEMESTANE (EXE)AS 3RD-LINE HORMONAL TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER (MBC) REFRACTORY TO TAMOXIFEN AND MEGACE(TM), Annals of oncology, 9, 1998, pp. 64-64
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
64 - 64
Database
ISI
SICI code
0923-7534(1998)9:<64:APSOAE>2.0.ZU;2-S